Products

Research.jpg

Endotelix has developed standardized anti-B2GP1 IgG ELISA for Human and Mouse

Coming soon: Endotelix will offers a APS mimic IgG with pathogenic properties of APS patients's IgG

national-cancer-institute-to8o0bqOA6Q-un

Because early diagnosis saves lives, Endotelix has developed fast, reliable and specific standardized solutions for clinical APS diagnostic tests.